Bristol Myers Squibb (BMY) Long-Term Debt Issuances (2017 - 2025)

Bristol Myers Squibb (BMY) has disclosed Long-Term Debt Issuances for 10 consecutive years, with $5.7 billion as the latest value for Q4 2025.

On a quarterly basis, Long-Term Debt Issuances changed N/A to $5.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.7 billion, a 55.45% decrease, with the full-year FY2025 number at $5.7 billion, down 55.45% from a year prior.
Long-Term Debt Issuances was $5.7 billion for Q4 2025 at Bristol Myers Squibb, down from $12.9 billion in the prior quarter.
In the past five years, Long-Term Debt Issuances ranged from a high of $12.9 billion in Q1 2024 to a low of $4.5 billion in Q4 2023.
A 4-year average of $7.3 billion and a median of $5.8 billion in 2022 define the central range for Long-Term Debt Issuances.

Peer Comparison